We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HD:NYSEHome Depot, Inc. (The) Analysis

Data as of 2026-03-09 - not real-time

$347.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Home Depot’s shares have rallied sharply after reporting a fourth‑quarter earnings beat and an increased dividend, lifting short‑term sentiment. The price is sitting just above a key support zone while the 20‑day and 200‑day moving averages are converging, suggesting a potential foothold. Technical momentum is mixed: the Relative Strength Index sits in oversold territory, yet the MACD remains in a bearish configuration, pointing to a cautious outlook. Volume is climbing, reinforcing the recent price action, but the broader market trend is neutral. Fundamentally, revenue has slipped year‑over‑year, and margins, while solid, are not expanding dramatically. Valuation metrics are stretched, with price multiples far above historical averages and a discounted cash‑flow model indicating a sizable gap. The dividend yield is attractive, and payout ratios are within a manageable range given cash flow, but the balance sheet carries a heavy debt load.
Looking ahead, the company’s strategic push to open new stores and deploy AI tools could underpin modest growth, yet the high valuation and cyclical exposure temper enthusiasm. Investors should weigh the short‑term upside from earnings momentum against medium‑term concerns over growth slowdown and leverage. The overall picture is one of a stock that is currently buoyed by positive news but faces long‑term valuation and risk headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Earnings beat and dividend increase driving price momentum
  • Oversold RSI indicating potential rebound
  • Rising volume supporting the move

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue contraction and high valuation multiples
  • Solid cash flow but elevated debt levels
  • Neutral technical outlook with bearish MACD

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Significant valuation gap versus DCF fair value
  • Heavy debt burden limiting financial flexibility
  • Cyclical industry exposure and modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-3.80%
Profit Margin8.60%
P/E Ratio24.4
ROE145.54%
ROA12.98%
Debt/Equity510.03
P/B Ratio26.9
Op. Cash Flow$16.3B
Free Cash Flow$8.6B

Technical Analysis

TrendNeutral
RSI30.8
Support$345.64
Resistance$397.63
MA 20$376.84
MA 50$372.23
MA 200$376.48
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Fair Value$55.81
Target Price$410.27
Upside/Downside18.07%
GradeOvervalued
TypeValue
Dividend Yield2.60%

Risk Assessment

Beta0.61
Volatility22.52%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.